Mid-Afternoon Market Update: Celator Pharmaceuticals Surges On Phase 3 Trial Results For Vyxeos; Constellium Shares Slide

March 15, 2016 at 14:46 PM EDT

Toward the end of trading Tuesday, the Dow traded up 0.04 percent to 17,236.39 while the NASDAQ declined 0.44 percent to 4,729.37. The ...